The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

Fdg Pet ◽

Renal Cell ◽

Kinase Inhibitors ◽

Early Response ◽

Pet Ct ◽

Fdg Pet Ct

Therapeutic Efficacy of Tyrosine Kinase Inhibitors Treatment for Metastatic Renal Cell Carcinoma Using 18F-FDG PET/CT

The Medical Journal of Cairo University ◽

10.21608/mjcu.2019.53352 ◽

2019 ◽

Vol 87 (March) ◽

pp. 1263-1271

Author(s):

TAMER W. KASSEM, M.D. MAGED A. HAWANA, M.D.

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Fdg Pet ◽

Renal Cell ◽

Therapeutic Efficacy ◽

Kinase Inhibitors ◽

Pet Ct ◽

18F Fdg ◽

Fdg Pet Ct

Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course

BMC Cancer ◽

10.1186/1471-2407-12-162 ◽

2012 ◽

Vol 12 (1) ◽

Cited By ~ 47

Author(s):

Daiki Ueno ◽

Masahiro Yao ◽

Ukihide Tateishi ◽

Ryogo Minamimoto ◽

Kazuhide Makiyama ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Fdg Pet ◽

Renal Cell ◽

Kinase Inhibitors ◽

Disease Course ◽

Early Assessment ◽

Pet Ct ◽

Fdg Pet Ct

Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

International Journal of Clinical Oncology ◽

10.1007/s10147-017-1166-2 ◽

2017 ◽

Vol 22 (6) ◽

pp. 1081-1086 ◽

Cited By ~ 12

Author(s):

Yosuke Yasuda ◽

Kazutaka Saito ◽

Takeshi Yuasa ◽

Sho Uehara ◽

Naoko Kawamura ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Early Response ◽

C Reactive Protein ◽

Reactive Protein

Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation

International Journal of Molecular Sciences ◽

10.3390/ijms18091937 ◽

2017 ◽

Vol 18 (9) ◽

pp. 1937 ◽

Cited By ~ 5

Author(s):

Girolamo Ranieri ◽

Ilaria Marech ◽

Artor Niccoli Asabella ◽

Alessandra Di Palo ◽

Mariangela Porcelli ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Advanced Renal Cell Carcinoma ◽

Response Evaluation ◽

Angiogenic Activity ◽

Pet Ct

MP16-06 EARLY RESPONSE AT FOUR WEEKS OF C-REACTIVE PROTEIN PREDICTS SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS

The Journal of Urology ◽

10.1016/j.juro.2017.02.512 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Yosuke Yasuda ◽

Kazutaka Saito ◽

Naoko Kawamura ◽

Sho Uehara ◽

Takeshi Yuasa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Early Response ◽

C Reactive Protein ◽

Reactive Protein

FDG PET/CT in the Evaluation of Late Manifestation of Adrenal Metastasis after Radical Nephrectomy in Patients with Renal Cell Carcinoma: A Report of Four Cases and Review of Literature

International Journal of Nuclear Medicine Research ◽

10.15379/2408-9788.2014.01.01.5 ◽

2014 ◽

Vol 1 (1) ◽

pp. 24-27

Author(s):

Koramadai Kamaleshwaran ◽

◽

Anish Bhattacharya ◽

Arup Mandal ◽

Shravan Singh ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Fdg Pet ◽

Renal Cell ◽

Radical Nephrectomy ◽

Adrenal Metastasis ◽

Review Of Literature ◽

Pet Ct ◽

Fdg Pet Ct ◽

Late Manifestation

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

Therapeutic Advances in Urology ◽

10.1177/17562872211029784 ◽

2021 ◽

Vol 13 ◽

pp. 175628722110297

Author(s):

Giandomenico Roviello ◽

Sebastiano Buti ◽

Carlo Cattrini ◽

Alessia Mennitto ◽

Carlo Messina ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Line Treatment ◽

First Line ◽

Increased Risk ◽

First Line Treatment

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors

OncoTargets and Therapy ◽

10.2147/ott.s45872 ◽

2013 ◽

pp. 679 ◽

Cited By ~ 1

Author(s):

Daniel Cho

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Prognostic Biomarkers ◽

Advanced Renal Cell Carcinoma

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

European Urology ◽

10.1016/j.eururo.2008.10.021 ◽

2009 ◽

Vol 55 (6) ◽

pp. 1430-1439 ◽

Cited By ~ 69

Author(s):

Manfred Johannsen ◽

Anne Flörcken ◽

Axel Bex ◽

Jan Roigas ◽

Marco Cosentino ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Retrospective Analysis ◽

Renal Cell ◽

Kinase Inhibitors ◽

Complete Response ◽

Response To Treatment

Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.10.002 ◽

2015 ◽

Vol 13 (4) ◽

pp. 280-286 ◽

Cited By ~ 13

Author(s):

Andreas Nearchou ◽

Antonis Valachis ◽

Pehr Lind ◽

Olof Akre ◽

Per Sandström

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Predictive Marker